enVVeno Medical Corp. Files Q1 2025 10-Q
Ticker: NVNO · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1661053
| Field | Detail |
|---|---|
| Company | Envveno Medical Corp (NVNO) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-devices, financials
TL;DR
enVVeno Medical Corp. filed its Q1 2025 10-Q, check financials for latest performance.
AI Summary
enVVeno Medical Corp. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Hancock Jaffe Laboratories, Inc., is based in Irvine, California, and operates in the surgical and medical instruments sector. This filing covers the first quarter of 2025, with financial data for the periods ending March 31, 2025, and March 31, 2024, as well as year-end data for 2024 and 2023.
Why It Matters
This 10-Q filing provides investors with an update on enVVeno Medical Corp.'s financial performance and operational status for the first quarter of 2025, crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: medium — As a medical device company, enVVeno Medical Corp. faces inherent risks related to product development, regulatory approvals, market adoption, and competition, which are typical for its industry.
Key Numbers
- 20250331 — Period End Date (The report covers financial data up to this date for Q1 2025.)
- 20240331 — Prior Year Period End Date (Comparative financial data for Q1 2024 is included.)
- 20241231 — Prior Year End Date (Year-end financial data for 2024 is referenced.)
Key Players & Entities
- enVVeno Medical Corp. (company) — Filer of the 10-Q report
- Hancock Jaffe Laboratories, Inc. (company) — Former name of enVVeno Medical Corp.
- 20250331 (date) — Conformed period of report
- 20250430 (date) — Filing date
- Irvine, CA (location) — Business and mailing address
FAQ
What were the key financial highlights for enVVeno Medical Corp. in the first quarter of 2025 compared to the same period in 2024?
The filing provides comparative financial data for the periods ending March 31, 2025, and March 31, 2024, but specific financial figures like revenue, net income, or loss are not detailed in the provided header information.
When was enVVeno Medical Corp. formerly known as Hancock Jaffe Laboratories, Inc. and when did the name change occur?
The company was formerly known as Hancock Jaffe Laboratories, Inc., and the date of the name change was December 15, 2015.
What is the primary business address and phone number for enVVeno Medical Corp.?
The business address is 70 Doppler, Irvine, CA 92618, and the business phone number is 949-261-2900.
What is the Standard Industrial Classification (SIC) code for enVVeno Medical Corp. and what does it represent?
The SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
What is the filing date and the period of report for this 10-Q filing?
The filing date is April 30, 2025, and the conformed period of report is March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding enVVeno Medical Corp (NVNO).